3 Biotechs That Have Investors Grinning at Thanksgiving Dinner This Year Post author:Sam Post published:November 20, 2017 Post category:BioPharma Investors have had a decent year, but some have much to be grateful for this Thanksgiving. Source: BioSpace You Might Also Like AcelRx Stopped Cold: FDA Rejects NDA for Pain Drug Dsuvia (ARX-04) October 11, 2017 <b>ENDECE</b> Opens San Francisco Office February 12, 2017 Teva, Union Reach Deal on HQ Layoffs for Administrative Staff January 4, 2018